Jay A. Lefton

Mr. Jay A. Lefton is a Director at Ontario Genomics Institute (Private Equity).
Mr. Lefton has served on the OGI's Board of Directors since 2006.
He is a partner at Borden Ladner Gervais in Toronto, where he is active in corporate and securities law, including public and private financings, mergers, acquisitions and take-over bids, private equity, and strategic alliances, technology transfer and licensing, with an emphasis on technology and life sciences companies.
He has served on the Ontario Securities Commission's Securities Advisory Committee, chaired the Board of Outside Advisors for the University of Toronto's Rotman School of Business, and been on the adjunct faculty at the Osgoode Hall School of Law (Toronto).
He sits on the Board of Directors of Pathways to Education Canada and is a director of the Ontario Neurotrauma Foundation (Toronto), ThinkFirst Foundation of Canada (Toronto), and was previously on the Board of the University of Toronto's Innovations Foundation.
Mr. Lefton is on the Board of Governors of Mount Sinai Hospital (Toronto) and Chair of the Cell Therapy Program Advisory Board of Princess Margaret Hospital (Toronto).
Mr. Lefton is also a member of the Adjudication Panel for the Premier's Catalyst Awards for innovation, sponsored by the Ontario Ministry of Research and Innovation.
Mr. Lefton earned his B.Comm.
(Hons) and LL.B. from the University of Toronto, and in 1983 joined the Ontario Bar.